CClinicalTrials.gg
CompletedNCT04869046Updated May 6, 2021

Levobupivacaine and Postoperative Pain Relief

A Phase 4 interventional study of Instillation of levobupivacaine in surgical wound in Postoperative Pain and Inguinal Hernia Unilateral, sponsored by Mother and Child Health Institute of Serbia Dr Vukan Cupic. Completed at 2 sites in Serbia. Open to participants aged 6 Months to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-06.

Sponsored by Mother and Child Health Institute of Serbia Dr Vukan Cupic · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 11 months after the study started (first participant enrolled Mar 2013, registered Feb 2020).
Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
6 Months to 7 Years
Sex
All
01

Study summary

The study analysed direct levobupivacaine instillation in surgical wound and its effectiveness in postoperative pain control. Half participants received 0,5 % levobupivacaine and the other half received 0,9% saline solution

Read the detailed description

Inguinal hernia is one of the most common conditions that requires elective surgical repair in children. The issue of post-operative pain in children is important, particularly because the surgical intervention per se is a stressful experience, after which the level of stressors in the recovery period should be minimized. Stress, including the pain in the postoperative period, could contribute to a delayed postoperative wound healing and recovery. Also, untreated acute pain could interfere with cognitive function, immune response as well as lead to the development of chronic postsurgical pain. For this reason, it is vital to reduce the painful sensations over the postoperative period as much as possible.

Levobupivacaine is a long-acting local anesthetic. Evidence from animal models and human volunteer participants showed that levobupivacaine has favourable effects on cardiovascular and central nervous systems. Clinical studies have also showed that levobupivacaine has a very low risk of systemic toxicity. A combination of levobupivacaine with non-opioid analgesics could have a beneficial role in the postoperative recovery from inguinal hernia surgery in terms of pain relief. The purpose of this study was to examine the effectiveness of levobupivacaine instillation combined with the routine postoperative non-opioid analgesia in children who underwent inguinal hernia repair.

It is very important for children to leave the hospital without additional support. Instilled levobupivacaine applied directly to the wound, currently interrupting transmission of the painful stimuli from the site of major trauma. The dose of applied levobupivacaine in this study is 2 times lower than that administered for caudal block and 4 times lower than the maximum dose. Analgesic effectiveness of this procedure is measured by the frequency of administration of a mixture of ibuprofen and acetaminophen over 24 hours after surgery, and duration of time between the administration of two doses.

02

Conditions studied

  • Postoperative Pain
  • Inguinal Hernia Unilateral

Keywords

  • postoperative pain
  • hernia
  • children
  • levobupivacaine
  • instillation
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 100 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Mother and Child Health Institute of Serbia Dr Vukan Cupic is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 7 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • elective surgery
  • not having incarcerated hernia
  • not having previous surgeries requiring general anaesthesia American Society of Anesthesia scores I and II
  • not having allergy to topical anesthetics, paracetamol, ibuprofen and/or general anesthetics, opioids or muscle relaxants

Exclusion criteria

Exclusion Criteria:

  • worsening of health status prior to surgery
  • parental withdrawal to study
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Levobupivacaine group

    Instillation of 0,1 ml/kg (0,5 mg/kg) levobupivacaine 0,5% in surgical wound before fascia closure

    Drug: Instillation of levobupivacaine in surgical wound

  • Placebo comparator
    Control Group

    Instillation of 0,1 ml/kg 0,9% Sodium Chloride in surgical wound before fascia closure

    Drug: Instillation of levobupivacaine in surgical wound

Interventions

  • DrugInstillation of levobupivacaine in surgical wound

    Once the hernia tissue had been surgically managed, the wound was sutured in layers and a solution of 0.5% levobupivacaine, 0.5 mg/kg (0.1 ml/kg), was instilled into the wound of children in the experimental group before suturing of the abdominal fascia. That same amount of 0.9% saline was given to children in the control group. The absorption of the solution took approximately 3 minutes, after which the wound was sutured. After completion of wound suturing, all children received 20 mg/kg of paracetamol administered as a rectal suppository.

    Also known as: Enteral analgesic mixture acetaminophen 10 mg/kg and ibuprofen 5mg/kg if needed, Acetaminophen, Ibuprofen

06

What researchers measure

Primary outcomes

  1. Postoperative pain assessment

    Assessment of pain by Face, Legs, Activity, Cry Consolability scale (nurse is observer) regularly, around the clock, first time 30 minutes after surgery, than after every 6 hours, until 24 h after surgery. Each score higher than 3 is considered significant and and an analgesic was given

    Time frame: "Min 30" if no changes "Hour 6"

  2. Analgesic efficacy of nonopioid analgesic mixture

    30 minutes after taking analgesic mixture, the Face, Legs, Activity, Cry Consolability pain scale assessment was performed. Each score higher than 3 is considered significant and planed nonopioid analgesic was given. Frequency of nonsteroidal anti-inflammatory drug administration needed in 24 hour timeframe and time interval between doses were used as a measure of the analgesic effectiveness

    Time frame: as needed in 24 hours

Secondary outcomes

  1. Control of breakthrough pain

    Breakthrough pain was treated with the same analgesic, in the same dose. The total allowed daily dose is taken into account. If it is exceeded, a dose of planned opioid analgesic is administered

    Time frame: as needed in 24 hours

07

Study locations

2 sites
  • Institut for Mother and Child HealthCare "Dr Vukan Cupic"
    Belgrade, +38111, Serbia
  • Institute for Mother and Child Health Care Dr Vukan Cupic
    Belgrade, Serbia
08

References and documents

Publications

  • Williams G, Howard RF, Liossi C. Persistent postsurgical pain in children and young people: prediction, prevention, and management. Pain Rep. 2017 Aug 21;2(5):e616. doi: 10.1097/PR9.0000000000000616. eCollection 2017 Sep. PubMed 29392231 ↗
  • Matsota P, Papageorgiou-Brousta M, Kostopanagiotou G. Wound infiltration with levobupivacaine: an alternative method of postoperative pain relief after inguinal hernia repair in children. Eur J Pediatr Surg. 2007 Aug;17(4):270-4. doi: 10.1055/s-2007-965473. PubMed 17806025 ↗
  • Dogra N, Dadheech R, Dhaka M, Gupta A. A study to compare caudal levobupivacaine, tramadol and a combination of both in paediatric inguinal hernia surgeries. Indian J Anaesth. 2018 May;62(5):359-365. doi: 10.4103/ija.IJA_747_17. PubMed 29910493 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04869046
Lead sponsor
Mother and Child Health Institute of Serbia Dr Vukan Cupic
Responsible party
Maja Sujica MD MS (Maja Sujica, Head of Department of Anesthesiology and Intensive Care, Mother and Child Health Institute of Serbia Dr Vukan Cupic) — Principal investigator
First posted
May 3, 2021
Start date
Mar 2013
Primary completion
Dec 2013
Completion
Dec 1, 2013
Last update
May 6, 2021

Study contacts

Sonja Vuckovic, MD, PhD
study director · University of Belgrade Faculty of Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion